Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,459 public trials 541 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Active, Not Recruiting

CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia

NCT04231851

Conditions
Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Hematologic Diseases, +6 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States
  • University of California, Davis Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
View Trial Details
Active, Not Recruiting

A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation

NCT03182244

Conditions
AML With FLT3 Mutation, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Site CN103 Beijing, China
  • Site CN108 Beijing, China
  • Site CN109 Beijing, China
  • Site CN110 Beijing, China
View all 49 locations
View Trial Details
Active, Not Recruiting

Hu8F4 in Treating Patients With Advanced Hematologic Malignancies

NCT02530034

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +31 more
Locations
  • Augusta University Augusta, Georgia, United States
  • Montefiore Medical Center, Albert Einstein College of Medicine The Bronx, New York, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details
Active, Not Recruiting

A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML

NCT03591510

Conditions
FLT3-mutated Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Novartis Investigative Site Prague, Czechia
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Essen, Germany
  • Novartis Investigative Site Pavia, PV, Italy
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies

NCT05453903

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Albert Einstein College Of Medicine New York, United States
View all 32 locations
View Trial Details

Related conditions